| Indicators | Browse All

Biomerica, Inc. (BMRA)

Healthcare | Medical Devices | Irvine, United States | NasdaqCM
2.14 USD +0.04 (1.905%) ⇧ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 2.14

Short-term:★⯪☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 4:46 a.m. EDT

The investment case for Biomerica is effectively broken by a decade-long structural collapse. While the forward P/E looks deceptively cheap at 4x, this is a classic value trap driven by a business that has lost 86% of its value over the last nine years. The company is currently bleeding cash, with negative operating and free cash flows, while revenue contracted by nearly 12% in the trailing twelve months. The recent quarterly loss of $0.44 per share, coupled with a complete lack of revenue disclosure, signals severe operational distress rather than a temporary glitch. Although the stock recently posted a marginal gain, this is insufficient to overcome the overwhelming evidence of deteriorating fundamentals. With no dividend to provide income and a balance sheet showing significant debt relative to equity, there is no margin of safety here. The statistical models show low confidence in short-term moves, which aligns with the chaotic nature of a failing business. Investors should avoid this security entirely.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.291761
AutoARIMA0.292822
AutoETS0.295888
AutoTheta0.365046

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 38%
H-stat 5.23
Ljung-Box p 0.000
Jarque-Bera p 0.138
Excess Kurtosis -0.88
Attribute Value
Sector Healthcare
Debt to Equity Ratio 5.819
Revenue per Share 1.608
Market Cap 6,613,176
Forward P/E 5.49
Beta 0.31
Profit Margins -96.46%
Website https://www.biomerica.com

Info Dump

Attribute Value
52 Week Change -0.3
Address1 17,571 Von Karman Avenue
All Time High 187.12
All Time Low 1.36
Ask 2.58
Ask Size 2
Average Daily Volume10 Day 334,820
Average Daily Volume3 Month 63,683
Average Volume 63,683
Average Volume10Days 334,820
Beta 0.313
Bid 1.54
Bid Size 2
Book Value 1.095
City Irvine
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.14
Current Ratio 2.641
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 2.15
Day Low 2.01
Debt To Equity 5.819
Display Name Biomerica
Earnings Timestamp End 1,756,756,800
Earnings Timestamp Start 1,756,238,400
Ebitda -5,268,000
Ebitda Margins -1.21747
Enterprise To Ebitda -1.038
Enterprise To Revenue 1.264
Enterprise Value 5,470,175
Eps Forward 0.39
Eps Trailing Twelve Months -1.64
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 949 553 1231
Fifty Day Average 1.665
Fifty Day Average Change 0.47500014
Fifty Day Average Change Percent 0.28528538
Fifty Two Week Change Percent -30.000002
Fifty Two Week High 3.22
Fifty Two Week High Change -1.0799999
Fifty Two Week High Change Percent -0.3354037
Fifty Two Week Low 1.45
Fifty Two Week Low Change 0.69000006
Fifty Two Week Low Change Percent 0.4758621
Fifty Two Week Range 1.45 - 3.22
Financial Currency USD
First Trade Date Milliseconds 463,411,800,000
Float Shares 2,774,011
Forward Eps 0.39
Forward P E 5.4871798
Free Cashflow -2,028,375
Full Exchange Name NasdaqCM
Full Time Employees 53
Fullday Change 0.0400002
Fullday Change Percent 1.90477
Fullday Price 2.14
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.04368
Gross Profits 189,000
Has Pre Post Market Data 1
Held Percent Insiders 0.10503
Held Percent Institutions 0.027929999
Implied Shares Outstanding 3,090,269
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ir Website http://www.biomerica.com/company/investor.asp
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,748,649,600
Last Split Date 1,745,193,600
Last Split Factor 1:8
Long Business Summary Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Long Name Biomerica, Inc.
Market us_market
Market Cap 6,613,176
Market State CLOSED
Max Age 86,400
Message Board Id finmb_254941
Most Recent Quarter 1,772,236,800
Net Income To Common -4,174,000
Next Fiscal Year End 1,780,185,600
Non Diluted Market Cap 6,489,564
Open 2.13
Operating Cashflow -3,170,000
Operating Margins -1.3151
Payout Ratio 0.0
Phone 949 645 2111
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 2.14
Post Market Time 1,787,959,805
Previous Close 2.1
Price Hint 4
Price To Book 1.954338
Price To Sales Trailing12 Months 1.5283513
Profit Margins -0.96463996
Quick Ratio 1.459
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0400002
Regular Market Change Percent 1.90477
Regular Market Day High 2.15
Regular Market Day Low 2.01
Regular Market Day Range 2.01 - 2.15
Regular Market Open 2.13
Regular Market Previous Close 2.1
Regular Market Price 2.14
Regular Market Time 1,787,947,201
Regular Market Volume 131,251
Return On Assets -0.54584
Return On Equity -0.94317
Revenue Growth -0.118
Revenue Per Share 1.608
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 3,090,269
Shares Percent Shares Out 0.0058999998
Shares Short 18,333
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 22,058
Short Name Biomerica, Inc.
Short Percent Of Float 0.0067000003
Short Ratio 2.9
Source Interval 15
State CA
Symbol BMRA
Total Cash 1,336,000
Total Cash Per Share 0.432
Total Debt 193,000
Total Revenue 4,327,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.64
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.13345
Two Hundred Day Average Change 0.0065500736
Two Hundred Day Average Change Percent 0.0030701791
Type Disp Equity
Volume 131,251
Website https://www.biomerica.com
Zip 92,614